English| Français| Nederlands| INDEX| CONTACT Argentina Australia Austria Belgium Brazil Canada Chile China Colombia Czech Republic Denmark Finland France Germany Greece Hungary India Ireland Italy Japan Korea Mexico The Netherlands New Zealand Norway Peru Poland Portugal Russia Romania Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Venezuela About Us | R&D | Products | News | Transparency | Careers About Us Our Mission Key Facts BMS in Belgium & Luxembourg Codes of Conduct Our History Home » About Us » Our History Our History The 'Squibb Corporation' was established in 1858 in Brooklyn by Dr. Edward Robinson Squibb. This company concentrated on the development of medicines. Bristol-Myers was established in 1887 by the founders William McLaren Bristol and John Ripley Myers. Together they bought a small pharmaceutical company in the northern part of the state of New York. Quality was central to the Bristol-Myers company from the very beginning. Before the merger between Bristol-Myers and Squibb was realized in 1989, both companies had developed parallel to each other for over a century. In the meantime Bristol-Myers Squibb has become a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. 1858: Dr. Squibb, American naval doctor, establishes a pharmaceutical laboratory in Brooklyn. 1887: Bristol and Myers, two young American graduates, buy a medicines factory in New York State. 1935: In Agen, France, Dr. Camille Bru establishes the UPSA (Union de Pharmacologie Scientifique Appliquée - The Union of Applied Scientific Pharmacology). 1962: The Bristol Benelux laboratories establish in Belgium, the Grand-Duchy of Luxembourg and the Netherlands. 1989: Bristol-Myers and Squibb merge. 1994: Upsa becomes a 100% subsidiary of the Bristol-Myers Squibb Company. 1998: Creation of the "Institut Belge de la Douleur-UPSA-Belgisch Pijninstituut" [Belgian Institute for Pain-UPSA]. Privacy Policy | Legal Notice | Pharmacovigilance | Contact This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact us on + 32/ 2.352.76.11 or e-mail: safety_belgium@bms.com ©2016 Bristol-Myers Squibb Belgium, Parc de l’Alliance, 4 Avenue de Finlande 1420 Braine l’Alleud. All company names and logos of BMS and / or the products of the company are trademarks of Bristol-Myers Squibb Company and / or affiliates, and are protected by national and international intellectual and industrial property laws. All rights to the contents of this website are reserved. Your use of this website is subject to the Legal Notice, the Privacy Policy, and the applicable laws and regulations.